The Belgian SME, created in 2010, is a clinical research organisation (CRO) specialised in developing solutions based on specific and innovative biomarkers in the context of precision medicine and personalized healthcare of musculoskeletal disorders & age-related diseases (osteoarthritis, inflammation, cartilage degradation, bone metabolism, metabolic disorders, cardiovascular, sarcopenia...)
Through the design and development of innovative biomarker-based solutions, its mission is to address unmet needs for product development in musculoskeletal disorders and age-related diseases.
From preclinical studies to postmarketing clinical trials, the SME provides scientific expertise, research and development support services, and tools for the evaluation of clinical, structural, and biological impact of a compound on musculoskeletal health.
Along with its diagnostic kits, the company offers technical and scientific support to its clients. These clients are in general researchers, businesses (biotech food, nutraceutical, pharmaceuticals, other clinical research organisations), local distributors, research centers and universities.
The company works at increasing its presence on the international market and access new markets, offering its specific added-value in terms of expertise and support.
In this perspective it is aiming at developing long-term partnerships under distribution agreement with partners such as companies in the pharmaceutical sector or biotechnological agrofood sector, or local distributors.
It is also willing to develop partnerships under distribution agreements with researchers, research centers or universities.